Download PDF
Thromb Haemost 1969; 21(01): 117-128
DOI: 10.1055/s-0038-1653518
Originalarbeiten - Original Article - Travaux Originaux
Schattauer GmbH

Serum Effects Following Tissue Thromboplastin Infusion

T Astrup
1   James F. Mitchell Foundation, Institute for Medical Research, Washington, D. C. 20015, U.S. A
,
O. K Albrechtsen   *
1   James F. Mitchell Foundation, Institute for Medical Research, Washington, D. C. 20015, U.S. A
› Author AffiliationsThis work was supported by Grant HE-05020 from the U.S. Public Health Service, National Institutes of Health, National Heart Institute, and by a grant-in-aid from the Warner-Lambert Research Institute.
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

Summary

Tissue thromboplastin injected into the femoral vein of anesthetized rabbits produced intravascular clotting in the vessels through which the thromboplastin flowed. In the systemic arteries macroscopically visible clots were never observed. No trace of tissue thromboplastin could be demonstrated in blood drawn from the carotid artery following infusion of tissue thromboplastin into the femoral vein. The slight, transient enhancement of coagulation of the arterial blood following tissue thromboplastin infusion was caused by a serum effect. After intravenous injection of serum, enhanced activation of coagulation could be observed for a period of up to 2 hrs. It is concluded that tissue thromboplastin, intravenously injected, is removed from the blood during its passage from the femoral vein to the systemic arteries, probably in the capillaries of the lung. True hypercoagulability appears to be due to a serum effect or caused by partial activation of the intrinsic coagulation system. The levels of coagulation precursors in blood are of minor significance.

* Recipient of a Fulbright Travel Stipend, on leave of absence from the University of Aarhus, and the Department of Thoracic Surgery, Municipal Hospital, Aarhus, Denmark.


 

  • References

  • 1 Astrup T, Ollendorff P. Estimation of thromboplastin activation in plasma. Scand. J. clin. Lab. Invest 13: 377 1961;
    CrossrefPubMedGoogle Scholar
  • 2 Biggs RR, Macfarlane G. Human Blood Coagulation and its Disorders. Blackwell Scientific Publications; Oxford: 1962
    Google Scholar
  • 3 Botti RE, Ratnoff OD. Studies on the pathogenesis of thrombosis: An experimental “hypercoagulable” state induced by the intravenous injection of ellagic acid. J. Lab. clin. Med 64: 358 1964;
    PubMedGoogle Scholar
  • 4 Brakman P, Albrechtsen OK, Astrup T. A comparative study of coagulation and fibrinolysis in blood from normal men and women. Brit. J. Haemat 12: 74 1966;
    CrossrefPubMedGoogle Scholar
  • 5 Caen J. Platelet-like activity of serum in hemophilia. In: Hemophilia and Other Hemorrhagic States. Ed. Brinkhous KM. 257 University of North Carolina Press; Chapel Hill, N.C: 1959
    Google Scholar
  • 6 Graham JH, Emerson CP, Anglern TJ. Postoperative hypofibrinogenemia. Diffuse intravascular thrombosis after fibrinogen administration. New Engl. J. Med 257: 101 1957;
    CrossrefPubMedGoogle Scholar
  • 7 Halpern BN, Benacerraf B, Biozzi G. Quantitative study of granulopectic activity of reticulo-endothelial system; effect of ingredients present in India ink and of substances affecting blood clotting in vivo on fate of carbon particles administered intravenously in rats, mice and rabbits. Brit. J. exp. Path 34: 426 1953;
    PubMedGoogle Scholar
  • 8 Hartmann RC, Conley CL, Krevans JR. The effect of intravenous infusion of thromboplastin on “heparin tolerance”. J. clin. Invest 30: 948 1951;
    CrossrefPubMedGoogle Scholar
  • 9 Kauffmann HM, Clark RF, Fisher LM, Hume DM. Lethality of intravascular injection of spleen and liver cells. Ann. Surg 159: 227 1963;
    PubMedGoogle Scholar
  • 10 Lewis JH, Szeto ILF. Effects of intravenous tissue thromboplastin in dogs. Development of an anticoagulant. J. Lab. clin. Med 60: 261 1962;
    PubMedGoogle Scholar
  • 11 Lewis JH, Szeto ILF. Clearance of infused fibrin. Fed. Proc 24 Part I, # 4: 840 1965;
    PubMedGoogle Scholar
  • 12 Monkhouse FG, Milosevic S. Changes in fibrinogen level after infusion of thrombin and thromboplastin. Amer. J. Physiol 199: 1165 1960;
    PubMedGoogle Scholar
  • 13 Nye SW, Graham JB, Brinkhous KM. The partial thromboplastin time as a screening test for the detection of latent bleeders. Amer. J. med. Sci 243: 279 1962;
    CrossrefPubMedGoogle Scholar
  • 14 Ollendorff P. Improvements in the thrombin generation test. Thrombos. Diathes. haemorrh. (Stuttg.) 04: 244 1960;
    PubMedGoogle Scholar
  • 15 Penick GD. From hemophilia to thrombophilia. In: The Hemophilias. Ed. Brinkhous KM. 251 University of North Carolina Press; Chapel Hill, N.C: 1964
    Google Scholar
  • 16 Penick GD, Roberts HR, Webster WP, Brinkhous KM. Hemorrhagic states secondary to intravascular clotting. Arch. Path 66: 708 1958;
    PubMedGoogle Scholar
  • 17 Raker JW, Skinner DB. A method for measurement of passage of tumor cells through the isolated pulmonary circulation. Ann. Surg 158: 877 1963;
    CrossrefPubMedGoogle Scholar
  • 18 Rapaport SI, Chapman CG. Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. Amer. J. Med 27: 144 1959;
    CrossrefPubMedGoogle Scholar
  • 19 Ratnoff OD, Conley CL. Studies on afibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material. Bull. Johns Hopk. Hosp 88: 414 1951;
    PubMedGoogle Scholar
  • 20 Skjodt P. Clot promoting components in circulating blood in a case of abruptio placentae with afibrinogenemia. Actagynec. obstet, scand 46: 41 1967;
    PubMedGoogle Scholar
  • 21 Spaet TH. Studies on the in vivo behavior of blood coagulation product I in rats. Thrombos. Diathes. haemorrh. (Stuttg.) 08: 276 1962;
    PubMedGoogle Scholar
  • 22 Spaet TH, Cintron J. Clearance of blood coagulation product I in rabbits. Proc. Soc. exp. Biol. (N. Y.) 104: 498 1960;
    CrossrefPubMedGoogle Scholar
  • 23 Spaet TH, Cintron J, Kropatkin M. A technique for determining whole blood clotting times in plastic tubes. J. Lab. clin. Med 54: 467 1959;
    PubMedGoogle Scholar
  • 24 Spaet TH, Horowitz HI, Zucker-Franklin D, Cintron J, Biezenski JJ. Reticuloendothelial clearance of blood thromboplastin by rats. Blood 17: 196 1961;
    PubMedGoogle Scholar
  • 25 Spittell JA, Pascuzzi CA, Thompson JH, Owen CA. Accelerated thromboplastin generation in acute arterial occlusion complicating arteriosclerosis obliterans. Ann. intern. Med 55: 765 1961;
    CrossrefPubMedGoogle Scholar
  • 26 Thomas DP, Wessler S, Reimer SM. The relation of Factors XII, XI, and IX to hypercoagulable states. Thrombos. Diathes. haemorrh 09: 90 1963;
    PubMedGoogle Scholar
  • 27 Wessler S. Thrombosis in the presence of vascular stasis. Amer. J. Med 33: 648 1962;
    CrossrefPubMedGoogle Scholar
  • 28 Wessler S, Reiner L, Freiman DG, Reimer SM, Lertzman M. Seruminduced thrombosis. Studies of its induction and evaluation under controlled conditions in vivo. Circulation 20: 864 1959;
    CrossrefPubMedGoogle Scholar